The Jill Roberts Institute for Research in Inflammatory Bowel Disease

Advancing Discovery. Transforming Our Understanding of Inflammatory Disease.

Welcome to the Jill Roberts Institute for Research in Inflammatory Bowel Disease

At the Jill Roberts Institute for Research in Inflammatory Bowel Disease (JRI) at Weill Cornell Medicine, we are dedicated to advancing scientific discovery and transforming our understanding of inflammatory bowel disease (IBD) and related inflammatory disorders.

Through innovative basic and translational research, our investigators explore the complex interactions among the immune system, the microbiome, and the environment that influence health and disease. By bringing together expertise in immunology, microbiology, gastroenterology, and related disciplines, the Institute fosters a collaborative research environment that bridges fundamental discoveries with their potential clinical applications.

Our mission is to accelerate scientific breakthroughs, inspire the next generation of researchers, and contribute to the development of more effective strategies for the prevention, diagnosis, and treatment of inflammatory diseases.

Explore our research, meet our investigators, and discover how collaboration and scientific innovation are shaping the future of IBD research.

The Jill Roberts Institute for Research in Inflammatory Bowel Disease is pleased to introduce Iliyan D. Iliev, PhD, as Interim Director.

Dr. Iliev is a Professor of Immunology at Weill Cornell Medicine and an internationally recognized investigator whose research explores the complex relationships among the microbiome, the immune system, and inflammatory disease.

Since establishing his laboratory at Weill Cornell Medicine in 2014, Dr. Iliev has built a multidisciplinary research program focused on understanding how fungi and other microorganisms interact with the immune system and contribute to intestinal health, inflammation, and disease.

His work brings together immunology, microbiology, computational biology, and clinical research, reflecting the collaborative scientific approach central to the Institute's mission.

As Interim Director, Dr. Iliev brings extensive scientific expertise and a commitment to fostering interdisciplinary collaboration, supporting investigators, and advancing innovative research that deepens our understanding of IBD and related inflammatory conditions.

Learn more about Dr. Iliev's research and laboratory at Iliev Lab.

Our History & Legacy

The Jill Roberts Institute for Research in Inflammatory Bowel Disease (JRI) was established at Weill Cornell Medicine through the generous philanthropy of Jill Roberts, with a vision to advance innovative research in inflammatory bowel disease (IBD) and related immune-mediated disorders.

Under the founding leadership of David Artis, PhD, the Institute established a strong foundation of scientific excellence, bringing together investigators from diverse disciplines to address fundamental questions in mucosal immunology, host-microbiome interactions, and inflammatory disease.

Since its inception, JRI has cultivated a collaborative and multidisciplinary research environment, supported by innovative research programs, state-of-the-art core facilities, and investigator-driven scientific initiatives. These efforts have helped advance our understanding of the complex biological mechanisms underlying intestinal health and disease.

Building upon this foundation, the Institute remains committed to fostering scientific discovery, interdisciplinary collaboration, and translational research that may lead to improved approaches for the prevention and treatment of inflammatory diseases.

JRC

Iliyan D. Iliev, PhD

Interim Director,

Jill Roberts Institute for Research in Inflammatory Bowel Disease